![]() |
WNL |
ISIN | FR0011981968 |
Security | WNL |
Exchange | EUREX |
Type | Option |
Options
Exp. date | Type | Type |
---|---|---|
4/23 | 42 Calls | 41 Puts |
5/23 | 34 Calls | 34 Puts |
6/23 | 53 Calls | 52 Puts |
9/23 | 31 Calls | 30 Puts |
12/23 | 30 Calls | 30 Puts |
3/24 | 28 Calls | 28 Puts |
6/24 | 21 Calls | 21 Puts |
12/24 | 21 Calls | 21 Puts |
News
- Impel NeuroPharma to Present Trudhesa™ Data at 2022 Scientific Meeting of American Academy of Neurology
03/22/2022 / 13:00 - GlobeNewswire - Apollo to acquire Worldline for close to $2.3B - report
02/11/2022 / 13:32 - TeleTrader - National Headache Foundation Position Statement on the Treatment of Migraine
01/19/2022 / 21:13 - GlobeNewswire - Impel NeuroPharma Provides Updates on Trudhesa™ Launch and Recent Business Highlights
01/18/2022 / 14:05 - GlobeNewswire - Impel NeuroPharma Announces Trudhesa™ (Dihydroergotamine Mesylate) Nasal Spray is Now Available for Prescription for the Acute Treatment of Migraine
09/28/2021 / 14:30 - GlobeNewswire